Ginger Root's Effect on Bleeding Risk in Patients on Anticoagulant Therapy

Mechanism of Action and Bleeding Risk

• Ginger contains compounds that inhibit thromboxane synthetase and decrease platelet aggregation, as demonstrated in laboratory studies 1

Clinical Evidence on Bleeding Risk

• The Society for Perioperative Assessment and Quality Improvement (SPAQI) consensus statement recommends holding ginger supplements for 2 weeks before surgery due to potential bleeding risk 1

Interaction with Anticoagulant and Antiplatelet Medications

• Ginger may potentiate the effects of antiplatelet drugs through its inhibition of platelet aggregation 1
• While ginkgo and ginger do not appear to interact with warfarin at modest doses, caution is still warranted 2

Recommendations for Patients on Anticoagulant Therapy

• For patients on antiplatelet therapy or anticoagulants, ginger consumption should be consistent and moderate to avoid fluctuations in anticoagulant effect 2
• Patients should disclose ginger supplement use to healthcare providers, especially before surgical or endoscopic procedures 1

Monitoring Recommendations

• For patients on dual antiplatelet therapy who also consume ginger supplements, closer monitoring for signs of bleeding may be warranted 3

Clinical Approach

• Assess the patient's current anticoagulant/antiplatelet regimen 2
• Advise discontinuation of ginger supplements 2 weeks before any planned surgical procedure 1